
Dear Friends,
The last few months have been extremely productive regarding new research at the Davidoff Center.
The research staff at the Charles E Trobman Data Center for Research Development at The Davidoff Center continues to expand.
Dr. D. Margel joined the staff at Davidoff center as a cancer epidemiologist and data analyst. We are sure his work will flourish in the coming years.
Early detection of cancer, a major theme of research, is evolving very fast. Dr. N. Peled recently joined the Oncology Division, and started several protocols for early detection of pulmonary malignancies. His studies may help detect patients with less advanced disease, leading to an increased number of patients cured from lung cancer.
As described last year, we embarked in a large project of human tumors transplanted in a mouse model. This work is done in cooperation with I. Haviv PhD from Bar-Ilan University. In the last months we were successful in establishing several human tumors in mouse models and try to deliver better and more accurate therapies to patients based upon the animal model. This is one the very novel venues in cancer care.
Other projects such as treatment related toxicity in cooperation with Tel-Aviv University continue to produce many related publications.
As described in the past, due to our excellent standards and performance more studies have begun.
These years are extremely critical and exciting years in cancer research and we must do our utmost to continue to increase our research activity and become involved in many more new ideas in cancer research.
We continue to face increasing shortage in space and more sophisticate research facilities, personnel and personnel space, which are crucial for our ongoing work.
Your partnership continues to be vital to these efforts and your additional support is greatly needed as cancer research becomes more complicated, time consuming and expensive.
Glad to have you as our partners in the fight against cancer.
Sincerely,
Salomon. M. Stemmer, MD
Head of Research
Deputy Chief, Oncology Division, Oncology Institute
Davidoff Center, Rabin Medical Center
Barbara Abrams is a two-time survivor of breast cancer,
an Ashkenazi Jew and BRCA positive. Every
woman in her family, who has been
BRCA tested, has the gene and has been
affected by cancer in some way. Her grandmother,
aunt and cousin did not survive
the illness.
Naomi Cohen's story does not start with a diagnosis of breast cancer. It starts with her well before and well after that. Breast cancer is not who or what she is, but it is a fact of her life. The very good news – it was over 22 years ago. So if anyone needs hope, here is Naomi Cohen.
During the last few years, with the development of a new generation of linear accelerators, tremendous advances have been made in radiation therapy treatment for cancer patients.